ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,698Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 63

$441K Total Retail Price of All Prescriptions

Rank: 12 out of 63

211 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 211 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,447 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 346 346 1 1
LISINOPRIL 327 327 2 2
MIRTAZAPINE 306 305 3 8
METOPROLOL TARTRATE 301 299 4 7
OMEPRAZOLE 299 291 5 6
FUROSEMIDE 271 249 6 4
JANTOVEN 268 268 7 28
LIDOCAINE-PRILOCAINE 258 255 8 78
TRAMADOL HCL 236 222 9 12
SERTRALINE HCL 193 192 10 19
AMLODIPINE BESYLATE 186 186 11 3
PANTOPRAZOLE SODIUM 175 174 12 23
NAMENDA 170 170 13 24
DONEPEZIL HCL 167 167 14 14
POTASSIUM CHLORIDE 157 147 15 30
WARFARIN SODIUM 157 157 15 9
LACTULOSE 133 100 17 47
ESCITALOPRAM OXALATE 129 129 18 32
EXELON 128 128 19 80
CITALOPRAM HBR 102 102 20 11
QUETIAPINE FUMARATE 101 101 21 34
SIMVASTATIN 98 98 22 5
METFORMIN HCL 96 95 23 17
PRAVASTATIN SODIUM 90 83 24 16
NOVOLOG 88 88 25 52
TRAZODONE HCL 82 78 26 18
ATORVASTATIN CALCIUM 81 77 27 10
SANTYL 81 81 27 64
ATENOLOL 80 80 29 22
DIVALPROEX SODIUM 78 78 30 35
LANTUS 76 76 31 29
PHENYTOIN SODIUM EXTENDED 71 71 32 79
KLOR-CON M20 70 69 33 31
GABAPENTIN 69 69 34 21
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 67 35 66
IPRATROPIUM-ALBUTEROL 63 63 36 62
DIOVAN 59 59 37 41
PLAVIX 59 57 37 51
SEROQUEL 56 56 39 69
CLOPIDOGREL 55 53 40 37
DIGOXIN 54 54 41 50
METHOTREXATE 50 50 42 165
HYDROCHLOROTHIAZIDE 50 50 42 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.